Aclaris Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Update on Clinical and Commercial Developments
Go back to Aclaris Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Update on Clinical and Commercial Developments| (NASDAQ: ACRS) | Delayed: 5.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.50 | 52 Week High | $33.88 | |||
| Open | $5.50 | 52 Week Low | $14.12 | |||
| Day High | $5.50 | P/E | N/A | |||
| Day Low | $5.50 | EPS | $0.00 | |||
| Volume | 67 | |||||
| Pioneer Bankshares, Inc. (AMEX: NBI) | Delayed: 5.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.50 | 52 Week High | $5.50 | |||
| Open | $5.50 | 52 Week Low | $5.50 | |||
| Day High | $5.50 | P/E | 3.31 | |||
| Day Low | $5.50 | EPS | $1.66 | |||
| Volume | 0 | |||||
